Profarma has established technologies for:
- Ranibizumab
- Human growth hormone (hGH)
- Granulocyte colony stimulating factor (G-CSF)
- Granulocyte macrophage colony stimulating factor (GM-CSF)
- Stem cell factor (SCF)
- Interferon α-2a
- Interferon α-2b
All technologies are available for the license-out, further development, GMP material supply and/or tech transfer.